モノクローナル抗体治療薬の世界市場：インサイト・予測

• 英文タイトル：Global Monoclonal Antibody Therapeutics Market Insights, Forecast to 2025

• レポートコード：QYR9ST02959
• 出版社/出版日：QYResearch / 2019年9月2日
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、114ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥592,800 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,185,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートでは、世界のモノクローナル抗体治療薬市場について調査・分析し、以下の構成でお届け致します。モノクローナル抗体治療薬の種類別には、人間、人間化、キメラ、その他に、用途別には、病院、診療所、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別モノクローナル抗体治療薬売上データ
・地域別モノクローナル抗体治療薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別モノクローナル抗体治療薬市場規模：人間、人間化、キメラ、その他
・用途別モノクローナル抗体治療薬市場規模：病院、診療所、その他
・主要メーカーの企業情報：Pfizer、Bayer、Sanofi、Merck、GlaxoSmithKline、Roche、Novartis、AbbVie
・モノクローナル抗体治療薬の市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...

For transferring the insulin a device is used that is known as insulin patch pump. Owing to the presence of the adhesive, the insulin patch pump gets directly attached to the body. The presence of the adhesive avoids the requirement of the infusion set and tubing for attaching the pump to the body.The global Monoclonal Antibody Therapeutics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Monoclonal Antibody Therapeutics market based on company, product type, end user and key regions.

This report studies the global market size of Monoclonal Antibody Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Monoclonal Antibody Therapeutics in these regions.
This research report categorizes the global Monoclonal Antibody Therapeutics market by top players/brands, region, type and end user. This report also studies the global Monoclonal Antibody Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Bayer
Sanofi
Merck
GlaxoSmithKline
Roche
Novartis
AbbVie

Market size by Product
Human
Humanized
Chimeric
Others
Market size by End User
Hospitals
Clinics
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Monoclonal Antibody Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Monoclonal Antibody Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Monoclonal Antibody Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Monoclonal Antibody Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Monoclonal Antibody Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Monoclonal Antibody Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Study Coverage
1.1 Monoclonal Antibody Therapeutics Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Product
1.4.2 Human
1.4.3 Humanized
1.4.4 Chimeric
1.4.5 Others
1.5 Market by End User
1.5.1 Global Monoclonal Antibody Therapeutics Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Monoclonal Antibody Therapeutics Market Size
2.1.1 Global Monoclonal Antibody Therapeutics Revenue 2014-2025
2.1.2 Global Monoclonal Antibody Therapeutics Sales 2014-2025
2.2 Monoclonal Antibody Therapeutics Growth Rate by Regions
2.2.1 Global Monoclonal Antibody Therapeutics Sales by Regions
2.2.2 Global Monoclonal Antibody Therapeutics Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Monoclonal Antibody Therapeutics Sales by Manufacturers
3.1.1 Monoclonal Antibody Therapeutics Sales by Manufacturers
3.1.2 Monoclonal Antibody Therapeutics Sales Market Share by Manufacturers
3.1.3 Global Monoclonal Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Monoclonal Antibody Therapeutics Revenue by Manufacturers
3.2.1 Monoclonal Antibody Therapeutics Revenue by Manufacturers (2014-2019)
3.2.2 Monoclonal Antibody Therapeutics Revenue Share by Manufacturers (2014-2019)
3.3 Monoclonal Antibody Therapeutics Price by Manufacturers
3.4 Monoclonal Antibody Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Monoclonal Antibody Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Monoclonal Antibody Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Monoclonal Antibody Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Monoclonal Antibody Therapeutics Sales by Product
4.2 Global Monoclonal Antibody Therapeutics Revenue by Product
4.3 Monoclonal Antibody Therapeutics Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Monoclonal Antibody Therapeutics Breakdown Data by End User

6 North America
6.1 North America Monoclonal Antibody Therapeutics by Countries
6.1.1 North America Monoclonal Antibody Therapeutics Sales by Countries
6.1.2 North America Monoclonal Antibody Therapeutics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Monoclonal Antibody Therapeutics by Product
6.3 North America Monoclonal Antibody Therapeutics by End User

7 Europe
7.1 Europe Monoclonal Antibody Therapeutics by Countries
7.1.1 Europe Monoclonal Antibody Therapeutics Sales by Countries
7.1.2 Europe Monoclonal Antibody Therapeutics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Monoclonal Antibody Therapeutics by Product
7.3 Europe Monoclonal Antibody Therapeutics by End User

8 Asia Pacific
8.1 Asia Pacific Monoclonal Antibody Therapeutics by Countries
8.1.1 Asia Pacific Monoclonal Antibody Therapeutics Sales by Countries
8.1.2 Asia Pacific Monoclonal Antibody Therapeutics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Monoclonal Antibody Therapeutics by Product
8.3 Asia Pacific Monoclonal Antibody Therapeutics by End User

9 Central & South America
9.1 Central & South America Monoclonal Antibody Therapeutics by Countries
9.1.1 Central & South America Monoclonal Antibody Therapeutics Sales by Countries
9.1.2 Central & South America Monoclonal Antibody Therapeutics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Monoclonal Antibody Therapeutics by Product
9.3 Central & South America Monoclonal Antibody Therapeutics by End User

10 Middle East and Africa
10.1 Middle East and Africa Monoclonal Antibody Therapeutics by Countries
10.1.1 Middle East and Africa Monoclonal Antibody Therapeutics Sales by Countries
10.1.2 Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Monoclonal Antibody Therapeutics by Product
10.3 Middle East and Africa Monoclonal Antibody Therapeutics by End User

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Monoclonal Antibody Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer Monoclonal Antibody Therapeutics Products Offered
11.1.5 Pfizer Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Company Business Overview
11.2.3 Bayer Monoclonal Antibody Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bayer Monoclonal Antibody Therapeutics Products Offered
11.2.5 Bayer Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Business Overview
11.3.3 Sanofi Monoclonal Antibody Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Sanofi Monoclonal Antibody Therapeutics Products Offered
11.3.5 Sanofi Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Company Business Overview
11.4.3 Merck Monoclonal Antibody Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Merck Monoclonal Antibody Therapeutics Products Offered
11.4.5 Merck Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 Company Business Overview
11.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.5.4 GlaxoSmithKline Monoclonal Antibody Therapeutics Products Offered
11.5.5 GlaxoSmithKline Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Company Business Overview
11.6.3 Roche Monoclonal Antibody Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Roche Monoclonal Antibody Therapeutics Products Offered
11.6.5 Roche Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Company Business Overview
11.7.3 Novartis Monoclonal Antibody Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Novartis Monoclonal Antibody Therapeutics Products Offered
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 Company Business Overview
11.8.3 AbbVie Monoclonal Antibody Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.8.4 AbbVie Monoclonal Antibody Therapeutics Products Offered
11.8.5 AbbVie Recent Development

12 Future Forecast
12.1 Monoclonal Antibody Therapeutics Market Forecast by Regions
12.1.1 Global Monoclonal Antibody Therapeutics Sales Forecast by Regions 2019-2025
12.1.2 Global Monoclonal Antibody Therapeutics Revenue Forecast by Regions 2019-2025
12.2 Monoclonal Antibody Therapeutics Market Forecast by Product
12.2.1 Global Monoclonal Antibody Therapeutics Sales Forecast by Product 2019-2025
12.2.2 Global Monoclonal Antibody Therapeutics Revenue Forecast by Product 2019-2025
12.3 Monoclonal Antibody Therapeutics Market Forecast by End User
12.4 North America Monoclonal Antibody Therapeutics Forecast
12.5 Europe Monoclonal Antibody Therapeutics Forecast
12.6 Asia Pacific Monoclonal Antibody Therapeutics Forecast
12.7 Central & South America Monoclonal Antibody Therapeutics Forecast
12.8 Middle East and Africa Monoclonal Antibody Therapeutics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Monoclonal Antibody Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Monoclonal Antibody Therapeutics Product Picture
Table Monoclonal Antibody Therapeutics Market Segments
Table Key Manufacturers Monoclonal Antibody Therapeutics Covered
Table Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Monoclonal Antibody Therapeutics Sales Market Share by Product 2014-2025
Figure Human Product Picture
Table Major Manufacturers of Human
Figure Humanized Product Picture
Table Major Manufacturers of Humanized
Figure Chimeric Product Picture
Table Major Manufacturers of Chimeric
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Monoclonal Antibody Therapeutics Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Others
Figure Monoclonal Antibody Therapeutics Report Years Considered
Figure Global Monoclonal Antibody Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Monoclonal Antibody Therapeutics Sales 2014-2025 (K Units)
Table Global Monoclonal Antibody Therapeutics Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Monoclonal Antibody Therapeutics Sales by Regions 2014-2019 (K Units)
Table Global Monoclonal Antibody Therapeutics Sales Market Share by Regions 2014-2019
Figure Global Monoclonal Antibody Therapeutics Sales Market Share by Regions 2014-2019
Figure 2018 Global Monoclonal Antibody Therapeutics Sales Market Share by Regions
Table Global Monoclonal Antibody Therapeutics Revenue by Regions 2014-2019 (Million US$)
Table Global Monoclonal Antibody Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Monoclonal Antibody Therapeutics Revenue Market Share by Regions 2014-2019
Figure 2018 Global Monoclonal Antibody Therapeutics Revenue Market Share by Regions
Table Global Monoclonal Antibody Therapeutics Sales by Manufacturers (2014-2019) (K Units)
Table Global Monoclonal Antibody Therapeutics Sales Share by Manufacturers (2014-2019)
Figure Global Monoclonal Antibody Therapeutics Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Monoclonal Antibody Therapeutics Revenue by Manufacturers (2014-2019) (Million USD)
Table Monoclonal Antibody Therapeutics Revenue Share by Manufacturers (2014-2019)
Figure Monoclonal Antibody Therapeutics Value Share by Manufacturers in 2018
Table Key Manufacturers Monoclonal Antibody Therapeutics Price (2014-2019) (USD/Unit)
Table Monoclonal Antibody Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Monoclonal Antibody Therapeutics Product Type
Table Date of International Manufacturers Enter into Monoclonal Antibody Therapeutics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Monoclonal Antibody Therapeutics Sales by Product (2014-2019) (K Units)
Table Global Monoclonal Antibody Therapeutics Sales Share by Product (2014-2019)
Figure Global Monoclonal Antibody Therapeutics Sales Market Share by Product (2014-2019)
Figure Global Monoclonal Antibody Therapeutics Sales Market Share by Product in 2018
Table Global Monoclonal Antibody Therapeutics Revenue by Product (2014-2019) (Million US$)
Table Global Monoclonal Antibody Therapeutics Revenue Share by Product (2014-2019)
Figure Global Monoclonal Antibody Therapeutics Revenue Market Share by Product (2014-2019)
Figure Global Monoclonal Antibody Therapeutics Revenue Market Share by Product in 2018
Table Monoclonal Antibody Therapeutics Price by Product 2014-2019 (USD/Unit)
Table Global Monoclonal Antibody Therapeutics Sales by End User (2014-2019) (K Units)
Table Global Monoclonal Antibody Therapeutics Sales Share by End User (2014-2019)
Figure Global Sales Monoclonal Antibody Therapeutics Market Share by End User (2014-2019)
Figure Global Sales Monoclonal Antibody Therapeutics Market Share by End User in 2018
Figure North America Monoclonal Antibody Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure North America Monoclonal Antibody Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table North America Monoclonal Antibody Therapeutics Sales by Countries (2014-2019) (K Units)
Table North America Monoclonal Antibody Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 North America Monoclonal Antibody Therapeutics Sales Market Share by Countries
Table North America Monoclonal Antibody Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table North America Monoclonal Antibody Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Monoclonal Antibody Therapeutics Revenue Market Share by Countries
Figure United States Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure United States Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Canada Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table North America Monoclonal Antibody Therapeutics Sales by Product (2014-2019) (K Units)
Table North America Monoclonal Antibody Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 North America Monoclonal Antibody Therapeutics Market Share by Product
Table North America Monoclonal Antibody Therapeutics Sales by End User (2014-2019) (K Units)
Table North America Monoclonal Antibody Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 North America Monoclonal Antibody Therapeutics Market Share by End User
Figure Europe Monoclonal Antibody Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure Europe Monoclonal Antibody Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Monoclonal Antibody Therapeutics Sales by Countries (2014-2019) (K Units)
Table Europe Monoclonal Antibody Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Monoclonal Antibody Therapeutics Sales Market Share by Countries
Table Europe Monoclonal Antibody Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Europe Monoclonal Antibody Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Monoclonal Antibody Therapeutics Revenue Market Share by Countries
Figure Germany Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Germany Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure France Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure France Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure UK Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Italy Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Russia Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Monoclonal Antibody Therapeutics Sales by Product (2014-2019) (K Units)
Table Europe Monoclonal Antibody Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Europe Monoclonal Antibody Therapeutics Market Share by Product
Table Europe Monoclonal Antibody Therapeutics Sales by End User (2014-2019) (K Units)
Table Europe Monoclonal Antibody Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Europe Monoclonal Antibody Therapeutics Market Share by End User
Figure Asia Pacific Monoclonal Antibody Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Monoclonal Antibody Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Monoclonal Antibody Therapeutics Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Monoclonal Antibody Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Monoclonal Antibody Therapeutics Sales Market Share by Countries
Table Asia Pacific Monoclonal Antibody Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Monoclonal Antibody Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Monoclonal Antibody Therapeutics Revenue Market Share by Countries
Figure China Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure China Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Japan Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Korea Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure India Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure India Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Australia Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Monoclonal Antibody Therapeutics Sales by Product (2014-2019) (K Units)
Table Asia Pacific Monoclonal Antibody Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Monoclonal Antibody Therapeutics Market Share by Product
Table Asia Pacific Monoclonal Antibody Therapeutics Sales by End User (2014-2019) (K Units)
Table Asia Pacific Monoclonal Antibody Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Monoclonal Antibody Therapeutics Market Share by End User
Figure Central & South America Monoclonal Antibody Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Monoclonal Antibody Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Monoclonal Antibody Therapeutics Sales by Countries (2014-2019) (K Units)
Table Central & South America Monoclonal Antibody Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Monoclonal Antibody Therapeutics Sales Market Share by Countries
Table Central & South America Monoclonal Antibody Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Monoclonal Antibody Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Monoclonal Antibody Therapeutics Revenue Market Share by Countries
Figure Brazil Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Monoclonal Antibody Therapeutics Sales by Product (2014-2019) (K Units)
Table Central & South America Monoclonal Antibody Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Monoclonal Antibody Therapeutics Market Share by Product
Table Central & South America Monoclonal Antibody Therapeutics Sales by End User (2014-2019) (K Units)
Table Central & South America Monoclonal Antibody Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Monoclonal Antibody Therapeutics Market Share by End User
Figure Middle East and Africa Monoclonal Antibody Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Monoclonal Antibody Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Monoclonal Antibody Therapeutics Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Monoclonal Antibody Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Monoclonal Antibody Therapeutics Sales Market Share by Countries
Table Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Monoclonal Antibody Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Monoclonal Antibody Therapeutics Revenue Market Share by Countries
Figure GCC Countries Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Monoclonal Antibody Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Monoclonal Antibody Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Monoclonal Antibody Therapeutics Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Monoclonal Antibody Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Monoclonal Antibody Therapeutics Market Share by Product
Table Middle East and Africa Monoclonal Antibody Therapeutics Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Monoclonal Antibody Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Monoclonal Antibody Therapeutics Market Share by End User
Table Pfizer Company Details
Table Pfizer Monoclonal Antibody Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development

Table Bayer Company Details
Table Bayer Monoclonal Antibody Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Recent Development

Table Sanofi Company Details
Table Sanofi Monoclonal Antibody Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development

Table Merck Company Details
Table Merck Monoclonal Antibody Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development

Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Monoclonal Antibody Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development

Table Roche Company Details
Table Roche Monoclonal Antibody Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development

Table Novartis Company Details
Table Novartis Monoclonal Antibody Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development

Table AbbVie Company Details
Table AbbVie Monoclonal Antibody Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Recent Development

Table Global Monoclonal Antibody Therapeutics Sales Forecast by Regions 2019-2025 (K Units)
Table Global Monoclonal Antibody Therapeutics Sales Market Share Forecast by Regions 2019-2025
Table Global Monoclonal Antibody Therapeutics Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Monoclonal Antibody Therapeutics Revenue Market Share Forecast by Regions 2019-2025
Table Global Monoclonal Antibody Therapeutics Sales Forecast by Product 2019-2025 (K Units)
Table Global Monoclonal Antibody Therapeutics Sales Market Share Forecast by Product 2019-2025
Table Global Monoclonal Antibody Therapeutics Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Monoclonal Antibody Therapeutics Revenue Market Share Forecast by Product 2019-2025
Table Global Monoclonal Antibody Therapeutics Sales Forecast by End User 2019-2025 (K Units)
Table Global Monoclonal Antibody Therapeutics Sales Market Share Forecast by End User 2019-2025
Figure North America Monoclonal Antibody Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Monoclonal Antibody Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Monoclonal Antibody Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Monoclonal Antibody Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Monoclonal Antibody Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Monoclonal Antibody Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Monoclonal Antibody Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Monoclonal Antibody Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Monoclonal Antibody Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Monoclonal Antibody Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Monoclonal Antibody Therapeutics Value Chain
Table Monoclonal Antibody Therapeutics Customers List
Table Monoclonal Antibody Therapeutics Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

バイオシミラーモノクローナル抗体の世界市場：市場規模・現状・予測

Global Biosimilar Monoclonal Antibody Market Size, Status and Forecast 2019-2025
QYR9ST03834 2019年9月2日 92Pages
※当調査レポートでは、バイオシミラーモノクローナル抗体の世界市場について調査・分析し、バイオシミラーモノクローナル抗体の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（合成化学、バイオ製薬、その他）、...

モノクローナル抗体ベース製品の世界市場：市場規模・現状・予測

Global Monoclonal Antibody Based Products Market Size, Status and Forecast 2019-2025
QYR9ST03948 2019年9月2日 98Pages
※当調査レポートでは、モノクローナル抗体ベース製品の世界市場について調査・分析し、モノクローナル抗体ベース製品の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（癌、自己免疫、炎症性、感染性、微生物性、...

モノクローナル抗体カスタムサービスの世界市場：市場規模・現状・予測

Global Monoclonal Antibody Custom Service Market Size, Status and Forecast 2019-2025
QYR9ST03949 2019年9月2日 99Pages
※当調査レポートでは、モノクローナル抗体カスタムサービスの世界市場について調査・分析し、モノクローナル抗体カスタムサービスの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ラットカスタムモノクローナル...

次世代抗体療法の世界市場：市場規模・現状・予測

Global Next Generation Antibody Therapeutics Market Size, Status and Forecast 2019-2025
QYR9ST04976 2019年9月2日 90Pages
※当調査レポートでは、次世代抗体療法の世界市場について調査・分析し、次世代抗体療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗体薬物コンジュゲート（ADC）、二重特異性抗体（BsAbs）、Fc...

抗体薬物コンジュゲートの世界市場：インサイト・予測

Global Antibody Drug Conjugates Market Insights, Forecast to 2025
QYR9ST00775 2019年9月2日 117Pages
※本調査レポートでは、世界の抗体薬物コンジュゲート市場について調査・分析し、以下の構成でお届け致します。抗体薬物コンジュゲートの種類別には、アドセトリス、カドシラに、用途別には、乳癌、リンパ腫に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなど...

がんモノクローナル抗体の世界市場：インサイト・予測

Global Cancer Monoclonal Antibodies Market Insights, Forecast to 2025
QYR9ST01381 2019年9月2日 111Pages
※本調査レポートでは、世界のがんモノクローナル抗体市場について調査・分析し、以下の構成でお届け致します。がんモノクローナル抗体の種類別には、マウス抗体、キメラおよびヒト化抗体、完全ヒト化抗体、その他に、用途別には、肝臓、乳房、血液、脳、ホジキンおよび非ホジキンリンパ腫、結腸直腸、白血病、その他に、地...

乳がんモノクローナル抗体の世界市場：市場規模・現状・予測

Global Breast Cancer Monoclonal Antibodies Market Size, Status and Forecast 2019-2025
QYR9ST03163 2019年9月2日 100Pages
※当調査レポートでは、乳がんモノクローナル抗体の世界市場について調査・分析し、乳がんモノクローナル抗体の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ネイキッド型MAbs、抱合型Mabs）、用途別（...

世界の二重特異性抗体治療法市場：動向・競争分析

Global Bispecific Antibody Therapeutic Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
QYR9ST07256 2019年9月5日 116Pages
※本調査レポートでは、世界の二重特異性抗体治療法市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。二重特異性抗体治療法の種類別には、Fcリージョンベアリング、Fc領域欠如に、用途別には、骨科学、肺、呼吸器疾患、腫瘍...

抗炎症治療薬の世界市場：インサイト・予測

Global Anti-inflammatory Therapeutics Market Insights, Forecast to 2025
QYR9ST01883 2019年9月2日 113Pages
※本調査レポートでは、世界の抗炎症治療薬市場について調査・分析し、以下の構成でお届け致します。抗炎症治療薬の種類別には、抗炎症生物、NSAID、コルチコステロイドに、用途別には、病院、診療所に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに...

心的外傷後ストレス障害（PTSD）治療薬の世界市場：インサイト・予測

Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Insights, Forecast to 2025
QYR9ST02997 2019年9月2日 117Pages
※本調査レポートでは、世界の心的外傷後ストレス障害（PTSD）治療薬市場について調査・分析し、以下の構成でお届け致します。心的外傷後ストレス障害（PTSD）治療薬の種類別には、抗うつ薬、抗不安薬に、用途別には、病院、薬局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国...

モノクローナル抗体ベース製品の世界市場：市場規模・現状・予測 Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins. This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodie…
バイオシミラーモノクローナル抗体の世界市場：市場規模・現状・予測 Biosimilar monoclonal antibodies (mAbs) are complex, large proteins of the biosimilar family used by the immune system to identify and neutralize foreign bodies, such as bacteria, viruses, and others. These antibodies are normally administered in the treatment of diseases such as rheumatoid arthriti…
モノクローナル抗体カスタムサービスの世界市場：市場規模・現状・予測 Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…
次世代抗体療法の世界市場：市場規模・現状・予測 The ADCs segment held the largest market share in the historical period and is projected to hold a market share of over 50% by 2025. The Fc engineered antibodies segmented is projected to witness the fastest growth during the forecast period.Geographically, North America dominates the next-generatio…
がんモノクローナル抗体の世界市場：インサイト・予測 The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from oth…